Home » Stocks » AIKI

AIkido Pharma, Inc. (AIKI)

Stock Price: $0.972 USD -0.188 (-16.21%)
Updated Mar 4, 2021 1:14 PM EST - Market open
Market Cap 107.48M
Revenue (ttm) 9,000
Net Income (ttm) -11.69M
Shares Out 34.99M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 4
Last Price $0.972
Previous Close $1.160
Change ($) -0.188
Change (%) -16.21%
Day's Open 1.120
Day's Range 0.972 - 1.160
Day's Volume 10,720,701
52-Week Range 0.466 - 5.520

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 week ago

NEW YORK, Feb. 25, 2021 /PRNewswire/ -- The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have...

Other stocks mentioned: CMPS
PRNewsWire - 1 week ago

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the underwriter of its previously announced bought deal offering of c...

PRNewsWire - 1 week ago

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announced underwritten public offering of 46...

Benzinga - 2 weeks ago

Aikido Pharma Inc (NASDAQ: AIKI) has increased the size of the previously announced public offering to 46.8 million shares at $1.60 per share, with gross proceeds of $75 million. The previous ...

PRNewsWire - 2 weeks ago

NEW YORK, Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that due to demand, the underwriter has agreed to increase the size of the...

PRNewsWire - 2 weeks ago

NEW YORK, Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has entered into an underwriting agreement with H.C. Wainwright & ...

PRNewsWire - 1 month ago

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that on January 22, 2021, the Company received a letter from the Listing Q...

Benzinga - 1 month ago

Alkido Pharma (NASDAQ: AIKI) shares are trading higher after the company announced it executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applicatio...

Other stocks mentioned: CHNG, ISR
InvestorPlace - 1 month ago

Shares of AIKI stock are skyrocketing after Aikido Pharma announced a new patent agreement for the use of psilocybin for cancer treatments. The post Aikido Pharma News: Why AIKI Stock Is Soari...

PRNewsWire - 1 month ago

NEW YORK, Jan. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Patent License Agreement for technology that co...

PRNewsWire - 2 months ago

NEW YORK, Dec. 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the publication of positive results from its Artificial Intelligence/Machin...

PRNewsWire - 3 months ago

NEW YORK, Nov. 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (the "Company" or "AIkido") (NASDAQ: AIKI) today announced the results from the virtual 2020 Annual Meeting of Stockholders (the "Mee...

PRNewsWire - 4 months ago

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its preclinical work on its next-generation chemotherapeutic, ...

PRNewsWire - 5 months ago

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) today announced that its work with research partner, Cogia BioTech LTD (www.cogia.de), has delivered several key upda...

PRNewsWire - 5 months ago

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

PRNewsWire - 5 months ago

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

PRNewsWire - 6 months ago

NEW YORK, Aug. 14, 2020 /PRNewswire/ -- AIkido Pharma Inc.

PRNewsWire - 6 months ago

NEW YORK, Aug. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc.

PRNewsWire - 7 months ago

NEW YORK, July 9, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on its effort to identify compounds to potentially address the COV...

Benzinga - 10 months ago

Shares of nano-cap biotech Aikido Pharma Inc (NASDAQ: AIKI), are ripping higher following an announcement concerning worldwide licensing of an antiviral platform.

24/7 Wall Street - 10 months ago

Aikido Pharma Inc. (NASDAQ: AIKI) is not necessarily a household name, but on Tuesday its shares made waves.

About AIKI

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It... [Read more...]

Industry
Biotechnology
Founded
1967
CEO
Anthony Hayes
Employees
3
Stock Exchange
NASDAQ
Ticker Symbol
AIKI
Full Company Profile

Financial Performance

Financial Statements